CANCELLED - SECTION 7
section 7
on 04 Sep 2024
Last Applicant/ Owned by
66 Hudson Boulevard East
New York
NY
100012192
Serial Number
88491688 filed on 27th Jun 2019
Registration Number
7093814 registered on 27th Jun 2023
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
ETRAVAMO
Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, and autoimmune diseases
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, and autoimmune diseases
First Use Date in General
20th Oct 2022
First Use Date in Commerce
20th Oct 2022
Mark Details
Serial Number
No 88491688
Mark Type
No Service/Collective Mark
Attorney Docket Number
No T437017
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 04th Sep 2024 | NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED |
| 04th Sep 2024 | CANCELLED SECTION 7-TOTAL |
| 31st Aug 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 25th Jan 2024 | TEAS SECTION 7 SURRENDER RECEIVED |
| 25th Jan 2024 | REQUEST FOR SECT 7 TOTAL SURRENDER FILED |
| 27th Jun 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 27th Jun 2023 | REGISTERED-PRINCIPAL REGISTER |
| 20th May 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 19th May 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 02th May 2023 | STATEMENT OF USE PROCESSING COMPLETE |